Showing results (131-140 of 158) with videos related to

Sort By:
Pageof 16
Swiss Medical Weekly|June 26, 2025
Update on prevention and antimicrobial prophylaxis of infective endocarditisMaryam Pavlicek-Bahlo, Barbara Hasse, Michelle Frank, et al.
Antibiotics (Basel, Switzerland)|October 25, 2024
Target Attainment and Population Pharmacokinetics of Cefazolin in Patients with Invasive Staphylococcus aureus Infections: A Prospective Cohort StudySeverin Bausch, Sarah Dräger, Panteleimon Charitos-Fragkakis, et al.
Shock (Augusta, Ga.)|February 27, 2019
Heparin-Binding Protein as a Prognostic Biomarker of Sepsis and Disease Severity at the Emergency DepartmentFredrik Kahn, Jonas Tverring, Lisa Mellhammar, et al.
JB & JS Open Access|April 13, 2026
Risk Factors for Discordance Between Synovial Fluid Culture and Intraoperative Cultures in Revision Arthroplasties: Results From a European Multicentre Observational StudyKarsten D Ottink, Flaminia Olearo, Danguole Vaznaisiene, et al.
Open Forum Infectious Diseases|December 10, 2021
A Multidimensional Cross-Sectional Analysis of Coronavirus Disease 2019 Seroprevalence Among a Police Officer Cohort: The PoliCOV-19 StudyParham Sendi, Rossella Baldan, Marc Thierstein, et al.
AIDS Research and Human Retroviruses|April 2, 2011
Molecular epidemiology of HIV type 1 CRF02_AG in Cameroon and African patients living in ItalyNazle Mendonca Collaço Véras, Maria Mercedes Santoro, Rebecca R Gray, et al.
Immunity, Inflammation and Disease|June 27, 2022
Serosurveillance after a COVID-19 vaccine campaign in a Swiss police cohortParham Sendi, Marc Thierstein, Nadja Widmer, et al.
Journal of Medical Virology|June 30, 2023
Do quantitative levels of antispike-IgG antibodies aid in predicting protection from SARS-CoV-2 infection? Results from a longitudinal study in a police cohortParham Sendi, Nadja Widmer, Mattia Branca, et al.
Trials|January 5, 2021
Recombinant human C1 esterase inhibitor (conestat alfa) in the prevention of severe SARS-CoV-2 infection in hospitalized patients with COVID-19: A structured summary of a study protocol for a randomized, parallel-group, open-label, multi-center pilot trial (PROTECT-COVID-19)Pascal Urwyler, Panteleimon Charitos, Stephan Moser, et al.
Viruses|April 30, 2021
SARS-CoV-2 Reinfection in a Healthcare Worker Despite the Presence of Detectable Neutralizing AntibodiesThomas Theo Brehm, Susanne Pfefferle, Ronald von Possel, et al.
Pageof 16